<DOC>
	<DOCNO>NCT01943097</DOCNO>
	<brief_summary>Neuroblastic tumor childhood neoplasms posse amino acid decarboxylase ( AADC ) activity Meta-iodobenzylguanidine ( MIBG ) , theoretically image ( 18 ) F-fluorodihydroxyphenylalanine ( ( 18 ) F-FDOPA ) ( 123 ) I-Meta-iodobenzylguanidine ( ( 123 ) I-MIBG ) PET , new specific diagnostic follow-up tool neuroendocrine tumor . In study , explore accuracy clinical role ( 18 ) F-FDOPA ( 123 ) I-MIBG PET neuroblastic tumor . METHODS : Patients tissue-proven neuroblastic tumor receive ( 18 ) F-FDOPA PET ( 123 ) I-MIBG initial diagnosis follow-up enrol . The sensitivity specificity ( 18 ) F-FDOPA ( 123 ) I-MIBG PET compare compare ( 18 ) F-FDG PET , use tumor histology standard .</brief_summary>
	<brief_title>Evaluation 18F-dopa 123I-MIBG Uptake Patients With Neuroblastoma</brief_title>
	<detailed_description />
	<mesh_term>Neuroblastoma</mesh_term>
	<criteria>( 1 ) Diagnosed clinical criterion ( one ) 1 . Proved Neuroblastoma pathological section 2 . Bone meta 24 hr urine VMA ( Vanillylmandelic acid ) HVA ( Homovanillic acid ) elevate 3 . CT MRI find tumor around adrenal gland Neuroblastic tumor ( 2 ) Age 030 year old，Body weight 2.5kg ( 3 ) Signed Inform Consent Form ( 1 ) AST ALT &gt; 200U/L、Cre &gt; 2.5mg/dl ( 2 ) Allerg 18Fdopa、123IMIBG ( 3 ) Subject fit study ( assessed PI ) ( 4 ) No need arrenge PET disease progress , assess VS</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>